Comparing the Efficacy and Safety of Venetoclax Combined with Hypomethylating Agents Versus Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Core Binding Factor Acute Myeloid Leukemia Patients
Blood Cancer Journal(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined